Fundraising Fox
Amphix Bio
Chicago, US · Delaware corporation
Find your way into Amphix Bio
Each arrow is one introduction. Sign up to fill in the first one.
Ask Matthias von Bismarck to introduce you to Nick Sather
You →Matthias · together at National Renewable Energy Laboratory →Nick
Sign up to find every way you can get introduced to Amphix Bio
- Your email: who you already know at Amphix Bio, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Amphix Bio team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Amphix Bio develops peptide therapeutics based on a supramolecular chemistry platform that forms nanostructure scaffolds to activate regenerative signaling in cells and tissues. Its pipeline targets neurological injuries, neuro-inflammatory diseases, and musculoskeletal disorders.
Founders & leadership
Board
Reported raises · per SEC filings
Form D private placements$10.3M disclosed across 1 round · 2025
▶$10.3MraisedDec 2025 · 9 investors · BiotechnologyRule 506(b)
- Samuel StuppExecutive Officer, Director
- Kok-Wai WongDirector
- Stephen R WilsonDirector
- John PotocsnakDirector
- Nicholas SatherExecutive Officer, Director
- Offering amount
- $12.5M
- Amount sold
- $10.3M
- First sale
- Dec 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Companies working in the same space as Amphix Bio.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Science Foundation | Phase I | 2022 | $252.9K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does Amphix Bio do?
- Amphix Bio develops peptide therapeutics based on a supramolecular chemistry platform that forms nanostructure scaffolds to activate regenerative signaling in cells and tissues. Its pipeline targets neurological injuries, neuro-inflammatory diseases, and musculoskeletal disorders.
- Who founded Amphix Bio?
- Amphix Bio was founded by Samuel Stupp, Nick Sather, Dévora Grynspan.
- How much funding has Amphix Bio raised?
- Amphix Bio has disclosed $10.3M raised across 1 round.
- Where is Amphix Bio headquartered?
- Amphix Bio is headquartered in Chicago, US.